Savient Pharmaceuticals

124 Washington St, Foxboro, Massachusetts, United Stateswww.savientpharma.com

Clinical Trials

0 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 3

50.0%

Phase 2

33.3%

Phase 1

16.7%

Trial Status Distribution

Completed

83.3%

Terminated

16.7%

Clinical Trials

Trials sponsored by this organization (6)

Study to Assess Pegloticase (KRYSTEXXA®) in Patients on Hemodialysis

Phase 1

Completed

interventional

Dec 201212 participants

Re-exposure Study of Pegloticase Intravenous (i.v.) in Symptomatic Gout Patients

Phase 3

Completed

interventional

May 20087 participants

Open-Label Extension Study for Patients Who Completed a Phase 3 Double-blind Study of PEG-uricase for Symptomatic Gout

Phase 3

Completed

interventional

Dec 2006151 participants

Safety and Efficacy Study of PEG-uricase in the Treatment of Hyperuricemic Patients With Symptomatic Gout

Phase 3

Completed

interventional

May 2006225 participants

A Study of Persons With Gout Who Do Not Respond to or Are Allergic to Conventional Therapy

Phase 2

Completed

interventional

Mar 200440 participants

Safety and Efficacy Study of Prosaptide to Treat Neuropathic Pain in HIV-Positive Patients

Phase 2

Terminated

interventional

Sep 2003350 participants

Approvals

No approval data available

News

No news articles found

Back to Organizations